Research study Program year 2021 Source: CMS Open Payments

A Phase 4 Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women

ClinicalTrials.gov NCT03886220

Research payments

$742,596

220 payments

Through program year 2021, $742,596 in research payments was reported against A Phase 4 Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women, across 220 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT03886220

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$742,596	220

Breakdown

Who paid Research payments · program year 2021

AbbVie, Inc. $742,596 220 payments

Who received the money Research payments · program year 2021

Gcp Clinical Research LLC Organisation paid for research $136,562 8 payments
Masters Of Clinical Research Inc Organisation paid for research $55,080 10 payments
Alliance For Multispecialty Research Organisation paid for research $43,130 11 payments
Clinical Trials Of Texas INC Organisation paid for research $37,437 13 payments
Genoma Research Group INC Organisation paid for research $36,325 6 payments
Medisense INC Organisation paid for research $34,924 7 payments
Southern Clinical Research Associate Organisation paid for research $34,299 7 payments
Georgia Research For Women Organisation paid for research $30,375 6 payments
Midtown Obgyn Organisation paid for research $28,903 8 payments
Advances In Health INC Organisation paid for research $27,971 14 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.